BE862089A - Nouveaux 3,20-dioxy-7alpha-halo-4-pregnenes et -1,4-pregnadienes et leur procede de preparation - Google Patents
Nouveaux 3,20-dioxy-7alpha-halo-4-pregnenes et -1,4-pregnadienes et leur procede de preparationInfo
- Publication number
- BE862089A BE862089A BE183654A BE183654A BE862089A BE 862089 A BE862089 A BE 862089A BE 183654 A BE183654 A BE 183654A BE 183654 A BE183654 A BE 183654A BE 862089 A BE862089 A BE 862089A
- Authority
- BE
- Belgium
- Prior art keywords
- pregnadienes
- pregnenes
- 7alpha
- dioxy
- halo
- Prior art date
Links
Classifications
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
- E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
- E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
- E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Architecture (AREA)
- Engineering & Computer Science (AREA)
- Civil Engineering (AREA)
- Mechanical Engineering (AREA)
- Structural Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75325676A | 1976-12-22 | 1976-12-22 | |
US05/753,257 US4076708A (en) | 1976-12-22 | 1976-12-22 | Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby |
Publications (1)
Publication Number | Publication Date |
---|---|
BE862089A true BE862089A (fr) | 1978-06-20 |
Family
ID=27115720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE183654A BE862089A (fr) | 1976-12-22 | 1977-12-20 | Nouveaux 3,20-dioxy-7alpha-halo-4-pregnenes et -1,4-pregnadienes et leur procede de preparation |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS604198B2 (fi) |
AR (1) | AR226806A1 (fi) |
AT (2) | AT373269B (fi) |
BE (1) | BE862089A (fi) |
DE (1) | DE2756550C2 (fi) |
DK (1) | DK153494C (fi) |
FI (1) | FI63947C (fi) |
FR (1) | FR2384793A1 (fi) |
GB (1) | GB1575983A (fi) |
HK (1) | HK584A (fi) |
HU (1) | HU179784B (fi) |
IE (1) | IE45950B1 (fi) |
IL (1) | IL53636A (fi) |
MY (1) | MY8500082A (fi) |
NL (1) | NL180479C (fi) |
NO (1) | NO151826C (fi) |
NZ (1) | NZ186031A (fi) |
PT (1) | PT67432B (fi) |
SE (1) | SE429865B (fi) |
SG (1) | SG58683G (fi) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109680036A (zh) | 2017-10-02 | 2019-04-26 | 爱科来株式会社 | 糖化蛋白质的测定 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429926A (en) * | 1964-05-25 | 1969-02-25 | Squibb & Sons Inc | 7-halo and 6-halo,6-dehydro a-norprogesterones |
-
1977
- 1977-12-13 GB GB51805/77A patent/GB1575983A/en not_active Expired
- 1977-12-19 FI FI773825A patent/FI63947C/fi not_active IP Right Cessation
- 1977-12-19 PT PT67432A patent/PT67432B/pt unknown
- 1977-12-19 NL NLAANVRAGE7714056,A patent/NL180479C/xx not_active IP Right Cessation
- 1977-12-19 IL IL53636A patent/IL53636A/xx unknown
- 1977-12-19 JP JP52152835A patent/JPS604198B2/ja not_active Expired
- 1977-12-19 NZ NZ186031A patent/NZ186031A/en unknown
- 1977-12-19 FR FR7738297A patent/FR2384793A1/fr active Granted
- 1977-12-19 AR AR270418A patent/AR226806A1/es active
- 1977-12-19 IE IE2576/77A patent/IE45950B1/en not_active IP Right Cessation
- 1977-12-19 DE DE2756550A patent/DE2756550C2/de not_active Expired
- 1977-12-19 AT AT0909477A patent/AT373269B/de not_active IP Right Cessation
- 1977-12-19 NO NO774359A patent/NO151826C/no unknown
- 1977-12-20 DK DK569977A patent/DK153494C/da not_active IP Right Cessation
- 1977-12-20 BE BE183654A patent/BE862089A/xx not_active IP Right Cessation
- 1977-12-20 SE SE7714538A patent/SE429865B/sv not_active IP Right Cessation
- 1977-12-21 HU HU77SCHE635A patent/HU179784B/hu unknown
-
1980
- 1980-11-25 AT AT0575980A patent/AT377566B/de not_active IP Right Cessation
-
1983
- 1983-09-09 SG SG586/83A patent/SG58683G/en unknown
-
1984
- 1984-01-05 HK HK5/84A patent/HK584A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY82/85A patent/MY8500082A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2384753B1 (fr) | Nouveaux thiols et leur procede de preparation | |
BE849794A (fr) | Derives de carbostyrile et leur procede de preparation | |
FR2349603A1 (fr) | Acrylamide-amidons et procede pour leur preparation | |
BE858236A (fr) | Nouveaux polyetherpolyols et leur procede de preparation | |
BE862578A (fr) | Electrocatalyseurs et procede pour leur preparation | |
FR2349579A1 (fr) | Derives de 1,2-dihydronaphtalene et leur procede de preparation | |
MC1174A1 (fr) | Nouveaux nucleosides et procede pour leur preparation | |
BE847090A (fr) | 15-steroides, et leur procede de preparation | |
BE862422A (fr) | Nouveaux derives de type succinimide et procede de leur preparation | |
OA05565A (fr) | Nouveaux dérivés du dithiole-1,2 et leur procédé de préparation. | |
OA05566A (fr) | Nouveaux dérivés du dithiole-1,2 et leur procédé de préparation. | |
BE861503R (fr) | Nouveaux derives d'isoxazoles, leur procede de preparation et leurs applications | |
BE856220A (fr) | Polyether-polyureides et procede de leur preparation | |
FR2301528A1 (fr) | Nouveaux composes 3-acyloxymethyl-cephemes et leur procede de preparation | |
BE855236A (fr) | Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation | |
BE858240A (fr) | Nouveaux derives du benzopyranne et leur procede de preparation | |
FR2353537A1 (fr) | Nouveaux derives aminomethylazoliques, leur procede de preparation et l | |
BE844229A (fr) | Nouveaux derives d'apovincaminol leur procede de preparation et leur application | |
BE851681A (fr) | 2,9-dioxatricyclo-4,3,03,7- decanes et procede pour leur preparation | |
FR2348189A1 (fr) | Nouveaux para-benzolethers basiques et procede pour leur preparation | |
BE848910A (fr) | Nouveaux fluorures de carbamate-carbamoyle et leur procede de preparation, | |
BE848627A (fr) | Derives substitues d'aminobenzaldehydes et leur procede de preparation, | |
FR2352821A1 (fr) | Nouveaux derives de thiazolorifamycine et leur procede de preparation | |
BE862089A (fr) | Nouveaux 3,20-dioxy-7alpha-halo-4-pregnenes et -1,4-pregnadienes et leur procede de preparation | |
BE841469A (fr) | Nouveaux composes 3-acyloxymethyl-cephem et leur procede de preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CCPA | Application for a supplementary protection certificate |
Free format text: 093C0101 |
|
CN | Change of patent owner's name | ||
CCPV | Grant of a supplementary protection certificate |
Free format text: 093C0101, EXPIRES 19990405 |
|
RE20 | Patent expired |
Owner name: SCHERING-PLOUGH LTD Effective date: 19971220 |